UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-KSB





[X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934 For the fiscal year ended December 31, 2002
                                           -----------------

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934 For the transition period from           to
                                                        ------------ ----------

Commission File Number: 000-33487

                            Pacific Technology, Inc.
                            -------------------------
             (Exact name of registrant as specified in its charter)
Delaware                                                             33-0954381
--------                                                             ----------
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
incorporation or organization)

26586 Guadiana, Mission Viejo, California                                 92691
-------------------------------------------------------------------------------
(Address of principal executive offices)                            (Zip Code)

                                  (866)571-6198
                                  -------------
              (Registrant's Telephone Number, Including Area Code)



Securities registered under Section 12(b) of the Act:


Title of each class registered:       Name of each exchange on which registered:
-------------------------------       ------------------------------------------
             None                                       None
             ----                                       ----

Securities registered under Section 12(g) of the Act:

                  Common Stock, Par Value $.001
                  -----------------------------
                         (Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.  [X] Yes  [ ] No

Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [ ]


State issuer's revenues for its most recent fiscal year. $1,466.

State the aggregate market value of the voting and non-voting common equity held
by non-affiliates computed by reference to the price at which the common equity
was sold, or the average bid and asked price of such common equity, as of a
specified date within the past 60 days. (See definition of affiliate in Rule
12b-2 of the Exchange Act.) As of March 26, 2003, approximately $0.

As of March 26, 2003, there were 8,895,000 shares of the issuer's $.001 par
value common stock issued and outstanding.

Documents incorporated by reference. There are no annual reports to security
holders, proxy information statements, or any prospectus filed pursuant to Rule
424 of the Securities Act of 1933 incorporated herein by reference.

Transitional Small Business Disclosure format (check one):

                         [ ]   Yes           [X]   No





                                       1
<PAGE>




                                     PART I

Item 1. Description of Business.
--------------------------------

Our Background.  We were incorporated in Delaware on March 2, 2000.

On March 7, 2003, we changed our name to Pacific Technology, Inc. On February
14, 2003, our Board of Directors unanimously approved an amendment to our
Certificate of Incorporation to change our corporate name to "Pacific
Technology, Inc." On February 14, 2003, our President, Secretary and director,
who owns in excess of the required majority of our outstanding common stock
necessary for the adoption of the action, approved the name change by action
taken by written consent. We changed our name because we have entered into a
letter of intent pursuant to which we will issue 6,030,000 shares of
our common stock to the shareholders of Pacific Technology, Inc., a Nevada
corporation ("PTI"), in exchange for 100% of the issued and outstanding shares
of PTI. We are currently finalizing a definitive agreement to
consummate this transaction.

Our Business. We were formed to be a provider of protein products, such as
protein bars and protein drinks, manufactured by a third party. We have only
generated minimal revenues from the sale of those protein bars. We anticipate
consummating the share exchange transaction with PTI as soon as we finalize the
definitive agreement.

PTI was incorporated pursuant to the laws of the State of Nevada on June 11,
2002. PTI distributes and sells optical storage items such as compact disc
recordable or CD-R and digital video disc recordable or DVD-R products and
accessories. PTI's product offering includes CD-Rs, DVD-Rs, CD and DVD labeling
systems, recording media and disc printers. PTI markets and sells products by
means of direct sales and by means of internet based advertising.

We anticipate abandoning our business of selling protein bars and plan to pursue
PTI's business plan once the transaction described above is complete. Therefore,
we plan to terminate our relationship with our product supplier and undertake
PTI's operations and adopt its marketing and growth strategy, utilize its
intellectual property, and anticipate operating in its competitive market.

Our Research and Development. We are not currently conducting any research and
development activities. We do not anticipate conducting such activities in the
near future. If we are not able to consummate the transaction with PTI described
above, we

Employees. As of March 26, 2003, we have one part time employee. We believe
that our relations with our employee are good. We are not a party to any
collective bargaining agreements.

Facilities. Our administrative office is located at 26586 Guadiana, Mission
Viejo, California 92691. We do not share this office with any other business. We
believe that our facilities are adequate for our needs and that additional
suitable space will be available on acceptable terms as required. We do not own
any real estate.

Item 2.  Description of Property.
---------------------------------

Property held by us. As of the date specified in the following table, we held
the following property:

====================================== ==========================
              Property                         December 31, 2002
-------------------------------------- --------------------------
Cash                                                     $47,623
====================================== ==========================

Our Facilities. Our headquarters are located at 26586 Guadiana, Mission Viejo,
California 92691. We believe that our facilities are adequate for our needs and
that additional suitable space will be available on acceptable terms as
required. We do not own any real estate.




                                       2
<PAGE>






Item 3.  Legal Proceedings.
--------------------------

There are no legal actions pending against us nor are any legal actions
contemplated by us at this time.

Item 4.  Submission of Matters to Vote of Security Holders
----------------------------------------------------------

There were no matters submitted to the vote of our security holders during the
period covered by this report.

                                     PART II

Item 5.  Market Price for Common Equity and Related Stockholder Matters.
------------------------------------------------------------------------

Reports to Security Holders. We are a reporting company with the Securities and
Exchange Commission, or SEC. The public may read and copy any materials filed
with the SEC at the SEC's Public Reference Room at 450 Fifth Street N.W.,
Washington, D.C. 20549. The public may also obtain information on the operation
of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC
maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically
with the SEC. The address of that site is http://www.sec.gov.

Our securities are not listed for trading on any exchange or quotation service.
We are not required to comply with the timely disclosure policies of any
exchange or quotation service. The requirements to which we would be subject if
our securities were so listed typically include the timely disclosure of a
material change or fact with respect to our affairs and the making of required
filings. Although we are not required to deliver an annual report to security
holders, we intend to provide an annual report to our security holders, which
will include audited financial statements.

There are 1,810,000 shares of our common stock which can be sold pursuant to
Rule 144 promulgated pursuant to the Securities Act of 1933. Rule 144 provides,
among other things, that persons holding restricted securities for a period of
one year may each sell, assuming all of the conditions of Rule 144 are
satisfied, in brokerage transactions every three months an amount of restricted
securities equal to one percent of our outstanding shares of common stock, or
the average weekly reported volume of trading during the four calendar weeks
preceding the filing of a notice of proposed sale, which ever is more. Rule 144
also provides that, after holding such securities for a period of two years, a
nonaffiliate of the company may sell those securities without restriction, other
than the requirement that we are current with respect to our information
reporting requirements.

In January 2002, our registration statement on Form SB-2 to register a total of
1,775,000 shares of common stock held by our shareholders was declared effective
by the SEC. The approximate number of holders of record of shares of our common
stock is thirty six. There are no outstanding options or warrants to purchase,
or securities convertible into, shares of our common stock.

There have been no cash dividends declared on our common stock. Dividends are
declared at the sole discretion of our Board of Directors.

Penny Stock Regulation. Shares of our common stock are subject to rules adopted
by the Securities and Exchange Commission that regulate broker-dealer practices
in connection with transactions in "penny stocks". Penny stocks are generally
equity securities with a price of less than $5.00 (other than securities
registered on certain national securities exchanges or quoted on the NASDAQ
system, provided that current price and volume information with respect to
transactions in those securities is provided by the exchange or system). The
penny stock rules require a broker-dealer, prior to a transaction in a penny
stock not otherwise exempt from those rules, deliver a standardized risk
disclosure document prepared by the Securities and Exchange Commission, which
contains the following:




                                       3
<PAGE>




o    a description of the nature and level of risk in the market for penny
     stocks in both public offerings and secondary trading;
o    a description of the broker's or dealer's duties to the customer and of the
     rights and remedies available to the customer with respect to violation to
     such duties or other requirements of securities' laws;
o    a brief, clear, narrative description of a dealer market, including "bid"
     and "ask" prices for penny stocks and the significance of the spread
     between the "bid" and "ask" price;
o    a toll-free telephone number for inquiries on disciplinary actions;
o    definitions of significant terms in the disclosure document or in the
     conduct of trading in penny stocks; and
o    such other information and is in such form (including language, type, size
     and format), as the Securities and Exchange Commission shall require by
     rule or regulation.

Prior to effecting any transaction in penny stock, the broker-dealer also must
provide the customer the following:

o    the bid and offer quotations for the penny stock;
o    the compensation of the broker-dealer and its salesperson in the
     transaction;
o    the number of shares to which such bid and ask prices apply, or other
     comparable information relating to the depth and liquidity of the market
     for such stock; and
o    monthly account statements showing the market value of each penny stock
     held in the customer's account.

In addition, the penny stock rules require that prior to a transaction in a
penny stock not otherwise exempt from those rules, the broker-dealer must make a
special written determination that the penny stock is a suitable investment for
the purchaser and receive the purchaser's written acknowledgment of the receipt
of a risk disclosure statement, a written agreement to transactions involving
penny stocks, and a signed and dated copy of a written suitably statement. These
disclosure requirements may have the effect of reducing the trading activity in
the secondary market for a stock that becomes subject to the penny stock rules.
Holders of shares of our common stock may have difficulty selling those shares
because our common stock will probably be subject to the penny stock rules.

Item 6.  Management's Discussion and Analysis of Financial Condition or Plan
of Operation.
-------------------------------------------------------------------------------

This following information specifies certain forward-looking statements of
management of the company. Forward-looking statements are statements that
estimate the happening of future events are not based on historical fact.
Forward-looking statements may be identified by the use of forward-looking
terminology, such as "may", "shall", "will", "could", "expect", "estimate",
"anticipate", "predict", "probable", "possible", "should", "continue", or
similar terms, variations of those terms or the negative of those terms. The
forward-looking statements specified in the following information have been
compiled by our management on the basis of assumptions made by management and
considered by management to be reasonable. Our future operating results,
however, are impossible to predict and no representation, guaranty, or warranty
is to be inferred from those forward-looking statements.

The assumptions used for purposes of the forward-looking statements specified in
the following information represent estimates of future events and are subject
to uncertainty as to possible changes in economic, legislative, industry, and
other circumstances. As a result, the identification and interpretation of data
and other information and their use in developing and selecting assumptions from
and among reasonable alternatives require the exercise of judgment. To the
extent that the assumed events do not occur, the outcome may vary substantially
from anticipated or projected results, and, accordingly, no opinion is expressed
on the achievability of those forward-looking statements. No assurance can be
given that any of the assumptions relating to the forward-looking statements
specified in the following information are accurate, and we assume no obligation
to update any such forward-looking statements.

Liquidity and Capital Resources. We had cash of $47,623 as of December 31, 2002.
Our total current assets and total assets were $47,623 as of December 31, 2002.
We believe that our available cash is sufficient to pay our day-to-day
expenditures for the next twelve months.

Our total liabilities were $59,788 as of December 31, 2002. We had $9,788 in
accounts payable and accrued expenses and $50,000 in a note payable to a related
party. In February 2003, the holder of that note agreed to convert the debt into
common stock at $.02 per share. We issued 2,500,000 shares to that party in
exchange for cancellation of the debt. We have no long-term commitments or
contingencies.

Results of Operations.

Revenues. For the year ended December 31, 2002 we had generated sales of $1,466,
less $1,106 for the cost of those goods sold, for a gross profit of $360. For
the year ended December 31, 2001, we had sales of $320, less $67 for cost of
goods sold, for a gross profit of $253. We anticipate that once we consummate
the transaction with PTI, as described above, we will generate increased
revenues from the operation of PTI's business.



                                       4
<PAGE>




Operating Expenses. For the year ended December 31, 2002, our total operating
expenses were $25,108 compared to $17,153 total operating expenses for the year
ended December 31, 2001. The majority of those expenses were legal and
professional fees, which totaled $21,087 for the year ended December 31, 2002,
compared to $14,282 for the year ended December 31, 2001. For the year ended
December 31, 2002, we experienced a net loss from operations of $24,748,
compared to a net loss from operations of $16,900 for the year ended December
31, 2001.

Our Plan of Operation for the Next Twelve Months. We have only generated minimal
revenues from operations. We anticipate consummating the transaction with PTI as
described above, and operating PTI's business thereafter. If we are not able to
consummate the transaction, we will reevaluate our future operating plans, which
may include pursuing another line of business or ceasing operations altogether.

We have cash of $47,623 as of December 31, 2002. In the opinion of management,
available funds will satisfy our working capital requirements for the next
twelve months. In addition, we have conducted informal negotiations with a
related party to acquire additional financing, which would be contingent on the
acquisition of PTI. If we are not able to consummate the acquisition of PTI, our
expenses will be limited to the day-to-day expenditures necessary to conduct
business. Our forecast for the period for which our financial resources will be
adequate to support our operations involves risks and uncertainties and actual
results could fail as a result of a number of factors.

We are not currently conducting any research and development activities, other
than attempting to consummate the transaction with PTI. Unless we complete the
transaction with PTI, we do not anticipate that we will purchase any significant
equipment. In the event that we begin to operate using PTI's business plan, then
we may need to hire additional employees or independent contractors as well as
purchase or lease additional equipment.

Item 7.  Financial Statements
-----------------------------



                                       5
<PAGE>






                              DR. PROTEIN.COM, INC.


                         REPORT AND FINANCIAL STATEMENTS

                           DECEMBER 31, 2002 AND 2001














                                       6
<PAGE>



                              DR. PROTEIN.COM, INC.


                                    CONTENTS





                                                                          PAGE
                                                                          ----
Independent Auditors' Report                                               8

Financial Statements

     Balance Sheet                                                         9

     Statements of Operations                                              10

     Statements of Changes in Stockholders' Equity (Deficit)               11

     Statements of Cash Flows                                              12

     Notes to Financial Statements                                         13









                                       7
<PAGE>






                          INDEPENDENT AUDITORS' REPORT
                          ----------------------------

March 21, 2003


To the Stockholders of
Dr. Protein.com, Inc.


We have audited the accompanying balance sheet of Dr. Protein.com, Inc. as of
December 31, 2002 and the related statements of operations, changes in
stockholders' equity, and cash flows for the year then ended. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits. The financial statements of Dr. Protein.com, Inc. for the year ended
December 31, 2001, were audited by other auditors whose report dated February
15, 2002, expressed an unqualified opinion on those statements.

We conducted our audits in accordance with auditing standards generally accepted
in the United States of America. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Dr. Protein.com, Inc. as of
December 31, 2002, and the results of its operations and its cash flows for the
year then ended in conformity with accounting principles generally accepted in
the United States of America.




                                                                 HALL & COMPANY
                                                             Irvine, California



                                       8
<PAGE>




                              DR. PROTEIN.COM, INC.

                                  BALANCE SHEET

                                DECEMBER 31, 2002






                                     ASSETS
                                     ------
Current assets
   Cash                                                           $      47,623
                                                                  -------------

     Total current assets                                                47,623

Other assets                                                                ---
                                                                  -------------

       Total assets                                               $      47,623
                                                                  =============



                 LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)
                 ----------------------------------------------

Current liabilities
   Accounts payable and accrued expenses                          $       9,788
   Related party note payable                                            50,000
                                                                  -------------

     Total current liabilities                                           59,788

Contingencies

Stockholders' Equity (Deficit)
   Preferred stock, $.001 par value;
     Authorized shares-- 5,000,000
     Issued and outstanding shares-- 0                                      ---
   Common stock, $.001 par value;
     Authorized shares-- 50,000,000
     Issued and outstanding shares-- 6,395,000                            6,395
   Additional paid-in capital                                            33,556
   Accumulated deficit                                                  (52,116)
                                                                  -------------

     Total stockholders' equity (deficit)                               (12,165)
                                                                  -------------

       Total liabilities and stockholders' equity                 $      47,623
                                                                  ==============





                 See accompanying notes to financial statements.

                                       9
<PAGE>



                              DR. PROTEIN.COM, INC.

                            STATEMENTS OF OPERATIONS

                     YEARS ENDED DECEMBER 31, 2002 AND 2001



<TABLE>
<CAPTION>
<S>                                                           <C>                 <C>
                                                              2002               2001
                                                         -------------       -------------

NET SALES                                                $       1,466       $         320

COST OF GOODS SOLD                                               1,106                  67
                                                         -------------       -------------

GROSS PROFIT                                                       360                 253

OPERATING EXPENSES
   Consulting services                                             500                 ---
   Legal and professional fees                                  21,087              14,282
   Other general and administrative expense                      1,205                 556
   Occupancy                                                     2,316               2,315
                                                         -------------       -------------

     Total operating expenses                                   25,108              17,153
                                                         -------------       -------------

LOSS FROM OPERATIONS                                           (24,748)            (16,900)

INTEREST EXPENSE                                                (2,038)                ---
                                                         -------------       -------------

LOSS BEFORE PROVISION FOR INCOME TAXES                         (26,786)            (16,900)

PROVISION FOR INCOME TAX EXPENSE (BENEFIT)                         800                 800
                                                         -------------       -------------

NET LOSS/COMPREHENSIVE LOSS                              $     (27,586)      $     (17,700)
                                                         =============       =============

NET LOSS/COMPREHENSIVE LOSS PER COMMON SHARE-- B
 ASIC AND DILUTED
                                                         $         ---       $         ---
                                                         =============       =============

WEIGHTED AVERAGE OF COMMON SHARES-- BASIC AND DILUTED
                                                             6,395,000           6,388,985
                                                         =============       =============
</TABLE>




                 See accompanying notes to financial statements.

                                       10
<PAGE>



                              DR. PROTEIN.COM, INC.

                  STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

                     YEARS ENDED DECEMBER 31, 2002 AND 2001


<TABLE>
<CAPTION>
<S>                                        <C>              <C>               <C>             <C>             <C>
                                              COMMON STOCK
                                       ----------------------------        PAID-IN               ACCUMULATED
                                          SHARES         AMOUNT            CAPITAL          DEFICIT         TOTAL
                                       ------------    ------------     -------------    -------------   -------------
Balance, December 31, 2000                3,400,000    $      3,400     $       1,930    $      (6,830)  $      (1,500)

Issuance of common stock, March
   18, 2001                               1,000,000           1,000             9,000              ---          10,000

Issuance of common stock, June 28,
   2001                                   1,995,000           1,995            17,955              ---          19,950

Cost of occupancy contributed by
   officer                                      ---             ---             2,315              ---           2,315

Net loss/comprehensive loss                     ---             ---               ---          (17,700)        (17,700)
                                       ------------    ------------     -------------    -------------   -------------

Balance, December 31, 2001                6,395,000    $      6,395     $      31,200    $     (24,530)  $      13,065

Expenses paid by officer                        ---             ---             2,356              ---           2,356

Net loss/comprehensive loss                     ---             ---               ---          (27,586)        (27,586)
                                       ------------    ------------     -------------    -------------   -------------

Balance, December 31, 2002                6,395,000    $      6,395     $      33,556    $     (52,116)  $     (12,165)
                                       ============    ============     =============    =============   =============
</TABLE>






                See accompanying notes to financial statements.

                                       11
<PAGE>



                              DR. PROTEIN.COM, INC.

                            STATEMENTS OF CASH FLOWS

                      YEAR ENDED DECEMBER 31, 2002 AND 2001


<TABLE>
<CAPTION>
<S>                                                                         <C>                    <C>
                                                                            2002                  2001
                                                                        -------------        --------------
CASH FLOWS FROM OPERATING ACTIVITIES
   Net loss                                                             $     (27,586)       $     (17,700)
   Adjustments to reconcile net loss to net cash used in operating
     activities
       Expenses paid by officer                                                 2,356                2,315
       Changes in operating assets and liabilities
         (Increase) decrease in inventory                                         487                 (487)
         Increase in accounts payable and accrued expenses                      7,248                1,040
                                                                        -------------        -------------

           Net cash used in operating activities                              (17,495)             (14,832)

CASH FLOWS FROM FINANCING ACTIVITIES
   Proceeds from issuance of common stock                                         ---               29,950
   Proceeds from related party note payable                                    50,000                  ---
                                                                        -------------        -------------

           Net cash provided by financing activities                           50,000               29,950
                                                                        -------------        -------------

NET INCREASE IN CASH                                                           32,505               15,118

CASH, beginning of year                                                        15,118                  ---
                                                                        -------------        -------------

CASH, end of year                                                       $      47,623        $      15,118
                                                                        =============        =============

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
   Income taxes paid                                                    $         800        $        800
                                                                        =============        =============
   Interest paid                                                        $         ---        $        ---
                                                                        =============        =============
</TABLE>




                 See accompanying notes to financial statements.

                                       12
<PAGE>



                              DR. PROTEIN.COM, INC.

                          NOTES TO FINANCIAL STATEMENTS

                           DECEMBER 31, 2002 AND 2001




Note 1 - BUSINESS DESCRIPTION AND SIGNIFICANT ACCOUNTING POLICIES

Business Description - Dr. Protein.com, Inc. (the "Company") was incorporated in
the state of Delaware on March 2, 2000. The Company provides protein bars and
drinks to professional and amateur athletes that participate in alternative or
extreme sports and other recreational activities such as surfing, snowboarding
and adventure racing via the Internet. The Company is headquartered in San
Clemente, California.

Cash Equivalents - For purposes of the balance sheet and statement of cash
flows, the Company considers all highly liquid debt instruments purchased with
maturity of three months or less to be cash equivalents.

Accounts Receivable - Receivables, if any, represent valid claims against
debtors for sales or other charges arising on or before the balance-sheet date
and are reduced to their estimated net realizable value.

Inventory - Inventory is stated at the lower of cost or market and is relieved
on the first-in, first-out method.

Fair Value of Financial Instruments - The carrying amount of the Company's
financial instruments, which includes cash, accounts receivable, accounts
payable and accrued expenses approximate their fair value due to the short
period to maturity of these instruments.

Revenue Recognition - The Company generally recognizes revenues services
provided to its customers are completed, fees are fixed or determinable, and
collectibility is probable. The Company's standard shipping terms are FOB
shipping point. Cost of goods sold consists of the purchase price of products
sold including inbound and outbound shipping charges, if any.

Income Taxes - The Company recognizes deferred tax assets and liabilities based
on differences between the financial reporting and tax bases of assets and
liabilities using the enacted tax rates and laws that are expected to be in
effect when the differences are expected to be recovered. The Company provides a
valuation allowance for deferred tax assets for which it does not consider
realization of such assets to be more likely than not.

Net Loss per Common Share - Pursuant to its subsequent incorporation on March 2,
2000, the Company adopted the provisions of Statement of Financial Accounting
Standards No. 128, "Earnings Per Share" ("SFAS 128"). SFAS 128 requires the
reporting of basic and diluted earnings/loss per share. Basic loss per share is
calculated by dividing net income (loss) by the weighted average number of
outstanding common shares during the year.





                                       13
<PAGE>



                              DR. PROTEIN.COM, INC.

                          NOTES TO FINANCIAL STATEMENTS

                           DECEMBER 31, 2002 AND 2001




Note 1 - BUSINESS DESCRIPTION AND SIGNIFICANT ACCOUNTING POLICIES (Continued)

Comprehensive Income/Loss - The Company applies Statement of Financial
Accounting Standards No. 130, "Reporting Comprehensive Income" ("SFAS 130").
SFAS 130 establishes standards for the reporting and display of comprehensive
income, requiring its components to be reported in a financial statement that is
displayed with the same prominence as other financial statements. For the
periods ended December 31, 2002 and December 31, 2001, the Company had no other
components of its comprehensive loss other than net loss as reported on the
statements of operations.

Accounting Estimates - The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ
from those estimates.


NOTE 2 - CONTINGENCIES

As shown in the accompanying financial statements, the Company has incurred a
net operating loss of approximately $51,800 since inception through the period
ended December 31, 2002.

To date, the Company has been focused on developing its brand name in the
alternative or extreme sports industry for its protein bars and drinks. The
Company currently has sponsor relationships with two professional surfers and
minimal revenues have occurred as of December 31, 2002. Management plans to
mitigate its losses in the near term through the significant reduction of legal
and professional fees that were incurred upon incorporation; for the preparation
of the Company's Private Offering Memorandum; and for the performance of audit
and review services. In addition, should management determine it necessary, the
Company will seek to obtain additional financing through the issuance of common
stock and increase of ownership equity.


NOTE 3 - ACCRUED EXPENSES

Accrued Wages and Compensated Absences - The Company currently does not have any
employees. The majority of development costs and services have been provided to
the Company by outside, third parties and by the founders. As such, there is no
accrual for wages or compensated absences as of December 31, 2002 and 2001.




                                       14
<PAGE>



                              DR. PROTEIN.COM, INC.

                          NOTES TO FINANCIAL STATEMENTS

                           DECEMBER 31, 2002 AND 2001




NOTE 4 - COMMON STOCK

On March 18, 2001, the Company issued 1,000,000 shares of its common stock to an
officer and director for cash of $10,000. Since the Company was drafting a
Private Placement Memorandum Offering (as described in the following paragraph),
the Company utilized the value of its common stock associated with that offering
of $0.01 per share. This amount was considered a reasonable estimate of fair
value between the Company and the officer.

On June 30, 2001, the Company completed a "best efforts" offering of its common
stock pursuant to the provisions of Section 4(2) of the Securities Act of 1933
and Rule 506 of Regulation D promulgated by the Securities and Exchange
Commission. In accordance with the Private Placement Memorandum Offering, which
was initiated on March 31, 2001, the Company issued 1,995,000 shares of its
common stock at $0.01 per share for a total of $19,950.


NOTE 5 - INCOME TAXES

At December 31, 2002, the Company has available for federal income tax purposes
net operating loss carryforwards of approximately $51,800 expiring at various
dates through 2022, which may be used to offset future taxable income.
Therefore, there is no provision for federal income taxes and only the minimum
state franchise tax of $800 has been provided for the year ended December 31,
2002.

In addition, the Company has deferred tax assets of approximately $8,000 at
December 31, 2002. The Company has not recorded a benefit from its net operating
loss carryforward because realization of the benefit is uncertain and,
therefore, a valuation allowance of ($8,000) has been provided for the deferred
tax assets by the Company's management.


NOTE 6 - RELATED PARTY TRANSACTIONS

The Company occupies office space provided by its officer. Accordingly,
occupancy costs have been allocated to the Company based on the square foot
percentage assumed multiplied by the officer's total monthly costs. These
amounts are shown in the accompanying statement of operations for the two years
in the period ended December 31, 2002 and are considered additional
contributions of capital by the officer to the Company.

On June 27, 2002, an officer of the Company loaned $50,000 to the Company. This
note bears no interest and is due on June 27, 2003.





                                       15
<PAGE>



                              DR. PROTEIN.COM, INC.

                          NOTES TO FINANCIAL STATEMENTS

                           DECEMBER 31, 2002 AND 2001




NOTE 7 - SUBSEQUENT EVENTS

On February 14, 2003, the Company issued 2,500,000 shares of its common stock
($.02 per share) to an officer in full satisfaction of the outstanding related
party note payable in the amount of $50,000.

Also on February 14, 2003, the Company's board of directors approved a name
change to PTI in contemplation of the potential acquisition of a company of the
same name.

On March 7, 2003, the Company entered into a letter of intent to acquire 100% of
the outstanding shares of common stock of PTI, a privately held Nevada
corporation, in exchange for 6,030,000 shares of the Company's common stock.
Definitive terms of the agreement have not been completed and accordingly, no
proforma financial information of PTI has been presented in these financial
statements.




                                       16
<PAGE>



The financial statements required by Item 7 are presented in the following
order:

Item 8.  Changes in and Disagreements with Accountants.
-------------------------------------------------------

On October 14, 2002, the Registrant's Board of Directors, voted to replace its
independent accountant, Quintanilla Accountancy Corporation ("Quintanilla").
Effective as of October 14, 2002, the Registrant's new independent accountant is
Hall & Company, certified public accountants ("Hall & Company"). The Registrant
retained the accounting firm of Hall & Company on October 14, 2002, as the
principal accountants to audit the Registrant's financial statements. The
Registrant authorized Quintanilla to respond fully to any inquiries from Hall &
Company and to make its work papers available to Hall & Company.

The reports of Quintanilla from March 2, 2000, the date of the Registrant's
inception, through October 14, 2002, did not contain any adverse opinion,
disclaimer of opinion, or qualification or modification as to the certainty,
audit scope or accounting principles. During March 2, 2000, the date of the
Registrant's inception, through October 14, 2002, there were no disagreements
between the Registrant and Quintanilla on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, which
disagreement, if not resolved to the satisfaction of the former independent
auditor, would have caused it to make reference to the subject matter of the
disagreement in connection with its report. In addition, during March 2, 2000
through October 14, 2002, there were no "reportable events" within the meaning
of Item 304 of the Securities and Exchange Commission's Regulation S-K.


                                    PART III

Item 9.  Directors, Executive Officers, Promoters and Control Persons.
----------------------------------------------------------------------

Executive Officers and Directors.

Our directors and principal executive officers are as specified on the following
table:

============================== ========== =====================================
                Name              Age                     Position
------------------------------ ---------- -------------------------------------
Michelle Mirrotto                 30      president, secretary, director
============================== ========== =====================================

Michelle Mirrotto. Ms. Mirrotto has been our president, secretary and one of our
directors since March 2001. Since 2000, Ms. Mirrotto has been employed by Sav-On
Drugs, where she is a pharmacist. From 1997 to 2000, Ms. Mirrotto attended the
University of the Pacific, where she graduated in 2000 with her Doctor of
Pharmacy. Ms. Mirrotto earned her Bachelor of Science degree in biology from
California State University, Fullerton in 1997. Ms. Mirrotto is not an officer
or director of any reporting company.

There are no orders, judgments, or decrees of any governmental agency or
administrator, or of any court of competent jurisdiction, revoking or suspending
for cause any license, permit or other authority to engage in the securities
business or in the sale of a particular security or temporarily or permanently
restraining any of our officers or directors from engaging in or continuing any
conduct, practice or employment in connection with the purchase or sale of
securities, or convicting such person of any felony or misdemeanor involving a
security, or any aspect of the securities business or of theft or of any felony,
nor are any of the officers or directors of any corporation or entity affiliated
with us so enjoined.



                                       17
<PAGE>



Our directors will serve until the next annual meeting of stockholders. Our
executive officers are appointed by our Board of Directors and serve at the
discretion of the Board of Directors.

Section 16(a) Beneficial Ownership Reporting Compliance. Our officers,
directors, and principal shareholders have filed all reports required to be
filed on, respectively, a Form 3 (Initial Statement of Beneficial Ownership of
Securities), a Form 4 (Statement of Changes of Beneficial Ownership of
Securities), or a Form 5 (Annual Statement of Beneficial Ownership of
Securities).

Item 10.  Executive Compensation
--------------------------------

Any compensation received by our officers, directors, and management personnel
will be determined from time to time by our Board of Directors. Our officers,
directors, and management personnel will be reimbursed for any out-of-pocket
expenses incurred on our behalf.

Summary Compensation Table. The table set forth below summarizes the annual and
long-term compensation for services in all capacities to us payable to our Chief
Executive Officer and our other executive officers whose total annual salary and
bonus are anticipated to exceed $50,000 during the year ending December 31,
2002. Our Board of Directors may adopt an incentive stock option plan for our
executive officers which would result in additional compensation.


<TABLE>
<CAPTION>
<S>                             <C>         <C>            <C>              <C>                   <C>
============================== ======= ============= ============= ===================== =====================
Name and Principal Position     Year      Annual      Bonus ($)        Other Annual           All Other
                                        Salary ($)                   Compensation ($)        Compensation
------------------------------ ------- ------------- ------------- --------------------- ---------------------
Michelle Mirrotto - president, 2002        None          None              None                  None
secretary
------------------------------ ------- ------------- ------------- --------------------- ---------------------
John D. Muellerleile - former  2002        None          None              None                  None
treasurer
------------------------------ ------- ------------- ------------- --------------------- ---------------------
Courtney Koepsell - former     2002        None          None              None                  None
treasurer
============================== ======= ============= ============= ===================== =====================
</TABLE>
Compensation of Directors. Our directors who are also our employees receive no
extra compensation for their service on our board of directors.

Employment Contracts. We are not party to any employment contracts with our sole
employee.

Stock Option Plan. We do not have any stock option plans in place.

Item 11. Security Ownership of Certain Beneficial Owners and Management.
------------------------------------------------------------------------

The following table sets forth certain information regarding the beneficial
ownership of our common stock as of March 26, 2003 by each person or entity
known by us to be the beneficial owner of more than 5% of the outstanding shares
of common stock, each of our directors and named executive officers, and all of
our directors and executive officers as a group.


                                       18
<PAGE>




<TABLE>
<CAPTION>
<S>                                         <C>                                  <C>                           <C>
================== ======================================== ==================================== ===============================
Title of Class     Name and Address of Beneficial Owner       Amount and Nature of Beneficial           Percent of Class
                                                                           Owner
------------------ ---------------------------------------- ------------------------------------ -------------------------------
Common Stock       Michelle Mirrotto
                   336 Plaza Estival                           5,600,000 shares, president,                  62.9%
                   San Clemente, CA 92672                           secretary, director
------------------ ---------------------------------------- ------------------------------------ -------------------------------
Common Stock       Ryan A. Neely
                   336 Plaza Estival                                 5,600,000 shares                        62.9%
                   San Clemente, CA 92672
------------------ ---------------------------------------- ------------------------------------ -------------------------------
Common Stock       All directors and named executive
                   officers as a group                               5,600,000 shares                        62.9%
                                                                                                             -----
================== ======================================== ==================================== ===============================
</TABLE>
On Michelle Mirrotto, who owns 5,000,000 shares is married to Ryan A. Neely, who
owns 600,000 shares. Therefore, each beneficially owns 5,600,000 shares of
common stock.

Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. In accordance with Securities and Exchange
Commission rules, shares of our common stock which may be acquired upon exercise
of stock options or warrants which are currently exercisable or which become
exercisable within 60 days of the date of the table are deemed beneficially
owned by the optionees. Subject to community property laws, where applicable,
the persons or entities named in the table above have sole voting and investment
power with respect to all shares of our common stock indicated as beneficially
owned by them.

Changes in Control. Our management is not aware of any arrangements which may
result in "changes in control" as that term is defined by the provisions of Item
403(c) of Regulation S-B.

Item 12.  Certain Relationships and Related Transactions.
---------------------------------------------------------

Related Party Transactions. There have been no related party transactions,
except for the following:

On September 22, 2001, Michelle Mirrotto, our president, secretary and one of
our directors, married Ryan A. Neely, one of our shareholders.

On March 3, 2000, Ryan A. Neely was issued 600,000 shares of our common stock in
exchange for his services as our promoter. The transaction was accounted for
based on the fair value of those services which was determined to be $600. We
also issued 1,250,000 shares to our other founders for services. The transaction
was accounted for based on the fair value of those services which was determined
to be $1,250. We also issued 1,550,000 shares to six individuals for legal
services that were provided to us. The transaction was accounted for based on
the fair value of those services which was determined to be $1,550.

On February 14, 2003, we issued 2,500,000 shares to Michelle Mirrotto, our sole
officer and director in exchange for cancellation of a debt we owed her in the
amount of $50,000, or $.02 per share.

Michelle Mirrotto, our president, secretary and one of our directors, has
provided office space to us at no charge.

With regard to any future related party transaction, we plan to fully disclose
any and all related party transactions, including, but not limited to, the
following:

o    disclosing such transactions in prospectuses where required;
o    disclosing in any and all filings with the Securities and Exchange
     Commission, where required;
o    obtaining disinterested directors consent; and
o    obtaining shareholder consent where required.



                                       19
<PAGE>



Item 13.  Exhibits and Reports on Form 8-K
------------------------------------------

(a) Exhibit No.
---------------
3.1                        Certificate of Incorporation*

3.2                        Bylaws*

* Included in the registration statement on Form SB-2 filed on August 10, 2001.

(b) Reports on Form 8-K
-----------------------

No reports on Form 8-K were filed during the last quarter of the period covered
by this annual report on Form 10-KSB, except for the following:

On October 16, 2002, we filed a report on Form 8-K to report a change in our
accountant.

On December 3, 2002, we filed a report on Form 8-K to report a change in our
address.



                                       20
<PAGE>




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned in the City of Newport Beach, California, on March 26, 2003.

                                  Pacific Technology, Inc.
                                  a Delaware corporation


                                  By:      /s/  Michelle Mirrotto
                                           ----------------------------------
                                           Michelle Mirrotto
                                  Its:     principal executive officer
                                           president, secretary, and a director


In accordance with the Exchange Act, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on the
dates indicated.



By:       /s/  Michelle Mirrotto                               March 26, 2003
         --------------------------------------------
         Michelle Mirrotto
Its:     principal executive officer
         president, secretary and a director







                                       21
<PAGE>




CERTIFICATIONS
--------------

I, Michelle Mirrotto, certify that:

1. I have reviewed this annual report on Form 10-KSB of Pacific Technology,
Inc.;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

         a) designed such disclosure controls and procedures to ensure that
         material information relating to the registrant, including its
         consolidated subsidiaries, is made known to us by others within those
         entities, particularly during the period in which this annual report is
         being prepared;

         b) evaluated the effectiveness of the registrant's disclosure controls
         and procedures as of a date within 90 days prior to the filing date of
         this annual report (the "Evaluation Date"); and

         c) presented in this annual report our conclusions about the
         effectiveness of the disclosure controls and procedures based on our
         evaluation as of the Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

         a) all significant deficiencies in the design or operation of internal
         controls which could adversely affect the registrant's ability to
         record, process, summarize and report financial data and have
         identified for the registrant's auditors any material weaknesses in
         internal controls; and

         b) any fraud, whether or not material, that involves management or
         other employees who have a significant role in the registrant's
         internal controls; and

6. The registrant's other certifying officers and I have indicated in this
annual report whether there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.
Date: March 26, 2003

/s/  Michelle Mirrotto
-----------------------
Michelle Mirrotto
Chief Executive Officer and Chief Financial Officer



                                       22
<PAGE>